Erasca Inc (ERAS) Hedge Fund Ownership (Q2 2026)

Q: Is it too late to buy Erasca Inc (ERAS) following the 2026 Q2 hedge fund 13F filings?

As of today, ERAS has moved +6.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +2.5% for the XLV sector ETF — an outperformance of +3.5%. Since the quarter end (June 30, 2026), ERAS gained +6.4% vs +8.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Erasca Inc (ERAS)

254 + Investors. Track Smart Money conviction in ERAS. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — ERAS

Based on 257 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q

For 3 consecutive quarters, more hedge funds added ERAS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

257 hedge funds hold ERAS right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +81% more funds vs a year ago

fund count last 6Q

+115 new funds entered over the past year (+81% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 61% buying

172 buying108 selling

Last quarter: 172 funds were net buyers (66 opened a brand new position + 106 added to an existing one). Only 108 were sellers (76 trimmed + 32 sold completely). A clear majority buying is a strong confirmation signal.

⚠️

Fewer new buyers each quarter (-30 vs last Q)

new funds entering per quarter

Funds opening this position for the first time: 16 → 34 → 96 → 66. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.

📌

Mixed — 34% long-term, 43% new

■ 34% conviction (2yr+) ■ 23% medium ■ 43% new

Of the 257 current holders: 87 (34%) held >2 years, 60 held 1–2 years, and 110 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

💰

Value +23% but shares only +6% — price-driven

Value

+22%

+6%

Last quarter: the total dollar value of institutional holdings rose +23%, but actual share count only changed +6%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

🚀

Acceleration phase — new buyers rushing in

25 → 16 → 34 → 96 → 66 new funds/Q

New funds entering each quarter: 16 → 34 → 96 → 66. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

🏛️

Veteran-anchored — 44% veterans vs 42% newcomers

■ 44% veterans ■ 14% 1-2yr ■ 42% new

Entry-cohort mix of 271 holders: 119 (44%) are 2+ year veterans, 39 entered 1–2 years ago, and 113 (42%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

✅

Strong quality — 34% AUM from major funds

34% from top-100 AUM funds

54 of 256 holders rank in the top 100 by AUM, accounting for 34% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

5.4

out of 10

Moderate Exit Risk

Exit risk score 5.4/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	254	223	13.9%
13F Shares	289M	275M	5.06%
Total Value	$4.77B	$4.04B	18.17%
New Positions	65	96	-31
Increased Positions	104	77	+27
Closed Positions	33	27	+6
Reduced Positions	71	38	+33
Total Calls	9	5	80.0%
Total Puts	6	5	20.0%
PUT/CALL Ratio	0.67	1.0	Bullish

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

254

223

13.9%

13F Shares

289M

275M

5.06%

Total Value

$4.77B

$4.04B

18.17%

New Positions

-31

Increased Positions

104

+27

Closed Positions

Reduced Positions

+33

Total Calls

80.0%

Total Puts

20.0%

PUT/CALL Ratio

0.67

1.0

Bullish

Institutional Holders (2026 Q2)

254 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ERAS. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 ERAS holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	ARCH Venture Management, LLC	11.81%	7,091,557	$129.9M
2	Frazier Life Sciences Management, L.P.	9.96%	24,975,188	$457.5M
3	Venrock Adviser, LLC	9.94%	17,891,812	$327.8M
4	Logos Global Management LP	9.58%	12,150,000	$222.6M
5	Vivo Capital, LLC	6.90%	4,127,412	$75.6M
6	KVP Capital Advisors, LP	6.12%	455,000	$8.3M
7	Cormorant Asset Management, LP	5.63%	6,000,000	$109.9M
8	Stempoint Capital LP	4.94%	1,565,913	$28.7M
9	Affinity Asset Advisors, LLC	4.35%	5,250,000	$96.2M
10	Siren, L.L.C.	4.23%	11,397,781	$208.8M
11	Acuta Capital Partners, LLC	3.39%	265,199	$4.9M
12	Paradigm Biocapital Advisors LP	3.28%	9,550,000	$175.0M
13	Rtw Investments, LP	2.81%	17,946,754	$328.8M
14	Silverarc Capital Management, LLC	2.40%	1,263,026	$23.1M
15	First Turn Management, LLC	2.39%	1,221,721	$22.4M
16	Soleus Capital Management, L.P.	1.70%	2,700,000	$49.5M
17	Spruce Street Capital LP	1.52%	422,543	$7.7M
18	Rock Springs Capital Management LP	1.25%	1,402,150	$25.7M
19	Seven Fleet Capital Management LP	0.93%	308,007	$5.6M
20	Integral Health Asset Management, LLC	0.72%	1,000,000	$18.3M
21	Samlyn Capital, LLC	0.67%	2,256,986	$41.3M
22	HighVista Strategies LLC	0.67%	160,328	$2.9M
23	Rhenman & Partners Asset Management AB	0.60%	349,000	$6.4M
24	Moody Aldrich Partners LLC	0.59%	177,939	$3.3M
25	Ishara Investments LP	0.55%	41,000	$751K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Erasca Inc (ERAS)

What does the Smart Money Trend signal show for ERAS?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added ERAS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ERAS?

More buyers than sellers — 61% buying: Last quarter: 172 funds were net buyers (66 opened a brand new position + 106 added to an existing one). Only 108 were sellers (76 trimmed + 32 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ERAS holders?

Strong quality — 34% AUM from major funds: 54 of 256 holders rank in the top 100 by AUM, accounting for 34% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held ERAS?

Mixed — 34% long-term, 43% new: Of the 257 current holders: 87 (34%) held >2 years, 60 held 1–2 years, and 110 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Erasca Inc (ERAS) following the 2026 Q2 hedge fund 13F filings?

As of today, ERAS has moved +6.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +2.5% for the XLV sector ETF — an outperformance of +3.5%. Since the quarter end (June 30, 2026), ERAS has gained +6.4% vs +8.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Erasca Inc (ERAS)

Smart Money Signals — ERAS

Buying streak — 3 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +81% more funds vs a year ago

More buyers than sellers — 61% buying

Fewer new buyers each quarter (-30 vs last Q)

Mixed — 34% long-term, 43% new

Value +23% but shares only +6% — price-driven

Acceleration phase — new buyers rushing in

Veteran-anchored — 44% veterans vs 42% newcomers

Strong quality — 34% AUM from major funds

Institutional Sentiment Summary — ERAS

Hedge Fund Ownership: ERAS

Market Analysis: ERAS

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: ERAS

Is It Too Late to Buy Erasca Inc (ERAS) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: ERAS

Statistics: ERAS

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Erasca Inc (ERAS)

Welcome to 13Foresight!